Sirio Pharma Co Ltd
SZSE:300791
Gross Margin
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
Peer Comparison
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| CN |
|
Sirio Pharma Co Ltd
SZSE:300791
|
6.3B CNY |
Loading...
|
|
| FR |
|
L'Oreal SA
PAR:OR
|
199.6B EUR |
Loading...
|
|
| UK |
|
Unilever PLC
LSE:ULVR
|
112.2B GBP |
Loading...
|
|
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.3T INR |
Loading...
|
|
| UK |
|
HALEON PLC
LSE:HLN
|
34.6B GBP |
Loading...
|
|
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
36.1B USD |
Loading...
|
|
| DE |
|
Beiersdorf AG
XETRA:BEI
|
18.4B EUR |
Loading...
|
|
| JP |
|
Kao Corp
TSE:4452
|
2.9T JPY |
Loading...
|
|
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.2T INR |
Loading...
|
|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
861.1B INR |
Loading...
|
|
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD |
Loading...
|
Market Distribution
| Min | -2 148% |
| 30th Percentile | 14.3% |
| Median | 23% |
| 70th Percentile | 34.6% |
| Max | 775.2% |
Other Profitability Ratios
Sirio Pharma Co Ltd
Glance View
Sirio Pharma Co. Ltd. manufactures dietary supplement products. The company is headquartered in Shantou, Guangdong and currently employs 2,456 full-time employees. The company went IPO on 2019-09-25. The firm's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The firm's own brand is WEWOW nutritional health food. The firm distributes its products both in the domestic market and to overseas markets.
See Also
Gross Margin is calculated by dividing the Gross Profit by the Revenue.
The current Gross Margin for Sirio Pharma Co Ltd is 31.6%, which is above its 3-year median of 30.6%.
Over the last 3 years, Sirio Pharma Co Ltd’s Gross Margin has increased from 30.3% to 31.6%. During this period, it reached a low of 29.4% on Jun 30, 2023 and a high of 31.6% on Sep 30, 2025.
